Cas9 as a versatile tool for engineering biology

Mali, Prashant, Esvelt, Kevin M, Church, George M·2013·Nature Methods

Cited by (999)

Items 201–300 of 999

  1. Efficient generation of gene-modified pigs via injection of zygote with Cas9/sgRNA
    Yong Wang, Yinan Du, Bin Shen, Xiaoyang Zhou, Jian Li, Yu Liu, Jian‐Ying Wang, Jiankui Zhou, Bian Hu, Nannan Kang et al. · 2015 · Scientific Reports
  2. Single Cell Transfection through Precise Microinjection with Quantitatively Controlled Injection Volumes
    Yu Ting Chow, Shuxun Chen, Ran Wang, Chichi Liu, Chi‐Wing Kong, Ronald A. Li, Shuk Han Cheng, Dong Bai Sun · 2016 · Scientific Reports
  3. CRISPR ‐Cas9‐mediated efficient directed mutagenesis and RAD 51‐dependent and RAD 51‐independent gene targeting in the moss Physcomitrella patens
    Cécile Collonnier, Aline Epert, Kostlend Mara, François Maclot, Anouchka Guyon‐Debast, Florence Charlot, Charles I. White, Didier G. Schaefer, Fabien Nogué · 2016 · Plant Biotechnology Journal
  4. Simple and Efficient Targeting of Multiple Genes Through CRISPR-Cas9 in Physcomitrella patens
    Mauricio Lopez‐Obando, Beate Hoffmann, Carine Géry, Anouchka Guyon‐Debast, Evelyne Téoulé, Catherine Rameau, Sandrine Bonhomme, Fabien Nogué · 2016 · G3 Genes Genomes Genetics
  5. Development of CRISPR/Cas9 for Efficient Genome Editing in Toxoplasma gondii
    Bang Shen, Kevin M. Brown, Shaojun Long, L. David Sibley · 2016 · Methods in molecular biology
  6. In Vitro Enzymology of Cas9
    Carolin Anders, Martin Jínek · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
  7. PIEZO2 is required for mechanotransduction in human stem cell–derived touch receptors
    K. Schrenk-Siemens, H. Wende, V. Prato, Kun Song, Charlotte Rostock, A. Loewer, J. Utikal, G. Lewin, S. G. Lechner, J. Siemens · 2014 · Nature Neuroscience
  8. Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases
    David G. Ousterout, Ami M. Kabadi, Pratiksha I. Thakore, Pablo Pérez‐Piñera, Matthew T Brown, William H. Majoros, Timothy E. Reddy, Charles A. Gersbach · 2014 · Molecular Therapy
  9. Efficient, Complete Deletion of Synaptic Proteins using CRISPR
    Salvatore Incontro, Cédric S. Asensio, Robert H. Edwards, Roger A. Nicoll · 2014 · Neuron
  10. edgeR: a versatile tool for the analysis of shRNA-seq and CRISPR-Cas9 genetic screens
    Zhiyin Dai, Julie M. Sheridan, Linden J. Gearing, Darcy Moore, Shian Su, Sam Wormald, Stephen Wilcox, Liam O’Connor, Ross A. Dickins, Marnie E. Blewitt et al. · 2014 · F1000Research
  11. Barth Syndrome: From Mitochondrial Dysfunctions Associated with Aberrant Production of Reactive Oxygen Species to Pluripotent Stem Cell Studies
    Ana Šarić, Karine Andréau, Anne‐Sophie Armand, Ian Max Møller, Patrice X. Petit · 2016 · Frontiers in Genetics
  12. New insights into the maternal to zygotic transition
    Alexander R. Langley, James C. Smith, Derek L. Stemple, Steven A. Harvey · 2014 · Development
  13. Genetic Modification for Wheat Improvement: From Transgenesis to Genome Editing
    Nikolai V. Borisjuk, Olena Kishchenko, Serik Eliby, Carly Schramm, Peter Anderson, Satyvaldy Jatayev, Akhylbek Kazhigulovich Kurishbayev, Yuri N. Shavrukov · 2019 · BioMed Research International
  14. Precision cancer mouse models through genome editing with CRISPR-Cas9
    Haiwei Mou, Zachary Kennedy, Daniel G. Anderson, Hao Yin, Wen Xue · 2015 · Genome Medicine
  15. A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene Regulation
    Iman Farasat, Howard M. Salis · 2016 · PLoS Computational Biology
  16. Non-viral delivery of genome-editing nucleases for gene therapy
    M Wang, Zachary Glass, Qiaobing Xu · 2016 · Gene Therapy
  17. Enabling tools for high-throughput detection of metabolites: Metabolic engineering and directed evolution applications
    Jyun‐Liang Lin, James M. Wagner, Hal S. Alper · 2017 · Biotechnology Advances
  18. Clinical trials of dual-target CAR T cells, donor-derived CAR T cells, and universal CAR T cells for acute lymphoid leukemia
    Juanjuan Zhao, Yongping Song, Delong Liu · 2019 · Journal of Hematology & Oncology
  19. Enhancer evolution and the origins of morphological novelty
    Mark Rebeiz, Miltos Tsiantis · 2017 · Current Opinion in Genetics & Development
  20. Identify Key Sequence Features to Improve CRISPR sgRNA Efficacy
    Lei Chen, Shaopeng Wang, Yuhang Zhang, Jiarui Li, Zhihao Xing, Jialiang Yang, Tao Huang, Yu‐Dong Cai · 2017 · IEEE Access
  21. New CRISPR Mutagenesis Strategies Reveal Variation in Repair Mechanisms among Fungi
    Valmik K. Vyas, G. Guy Bushkin, Douglas A. Bernstein, Matthew A. Getz, Magdalena Sewastianik, M. Inmaculada Barrasa, David P. Bartel, Gerald R. Fink · 2018 · mSphere
  22. CRISPR-based technologies: prokaryotic defense weapons repurposed
    Rebecca M. Terns, Michael P. Terns · 2014 · Trends in Genetics
  23. Functional genetics for all: engineered nucleases, CRISPR and the gene editing revolution
    Anna F. Gilles, Michalis Averof · 2014 · EvoDevo
  24. Generation of heritable germline mutations in the jewel wasp Nasonia vitripennis using CRISPR/Cas9
    Ming Li, Lauren Au, Deema Douglah, Abigail Chong, Bradley J. White, Patrick M. Ferree, Omar S. Akbari · 2017 · Scientific Reports
  25. Cas9 interrogates DNA in discrete steps modulated by mismatches and supercoiling
    Ivan E. Ivanov, Addison V. Wright, Joshua C. Cofsky, Kevin Aris, Jennifer A. Doudna, Zev D. Bryant · 2020 · Proceedings of the National Academy of Sciences
  26. The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
    Sameh A. Abdelnour, Long Xie, Abdallah A. Hassanin, Erwei Zuo, Yangqing Lu · 2021 · Frontiers in Cell and Developmental Biology
  27. Progress in Genome Editing Technology and Its Application in Plants
    Kai Zhang, Nadia Haingotiana Raboanatahiry, Bin Zhu, Maoteng Li · 2017 · Frontiers in Plant Science
  28. Variant-aware saturating mutagenesis using multiple Cas9 nucleases identifies regulatory elements at trait-associated loci
    Matthew C. Canver, Samuel Lessard, Luca Pinello, Yuxuan Wu, Yann Ilboudo, Emily N Stern, Austen J Needleman, F. Galactéros, Carlo Brugnara, Abdullah Kutlar et al. · 2017 · Nature Genetics
  29. Vectors and strategies for nonviral cancer gene therapy
    Jessica Pahle, Wolfgang Walther · 2015 · Expert Opinion on Biological Therapy
  30. TAL effectors: tools for DNA Targeting
    Radek Jankele, Petr Svoboda · 2014 · Briefings in Functional Genomics
  31. CRISPR/Cas9-mediated mutagenesis of the white and Sex lethal loci in the invasive pest, Drosophila suzukii
    Fang Li, Maxwell J. Scott · 2015 · Biochemical and Biophysical Research Communications
  32. CRISPR/Cas9 for Human Genome Engineering and Disease Research
    Xin Xiong, Meng Chen, Wendell A. Lim, Dehua Zhao, Lei S. Qi · 2016 · Annual Review of Genomics and Human Genetics
  33. Effect of CRISPR/Cas9-Mediated PD-1-Disrupted Primary Human Third-Generation CAR-T Cells Targeting EGFRvIII on In Vitro Human Glioblastoma Cell Growth
    Tsutomu Nakazawa, Atsushi Natsume, Fumihiko Nishimura, Takayuki Morimoto, Ryosuke Matsuda, Mitsutoshi Nakamura, Shuichi Yamada, Ichiro Nakagawa, Yasushi Motoyama, Young-Soo Park et al. · 2020 · Cells
  34. Harnessing CRISPR-Cas9 immunity for genetic engineering
    Emmanuelle Charpentier, Luciano A. Marraffini · 2014 · Current Opinion in Microbiology
  35. Efficient single-copy HDR by 5’ modified long dsDNA donors
    José Arturo Gutierrez-Triana, Tinatini Tavhelidse, Thomas Thumberger, Isabelle Thomas, Beate Wittbrodt, Tanja Kellner, Kerim Anlaş, Erika Tsingos, Joachim Wittbrodt · 2018 · eLife
  36. Making designer mutants in model organisms
    Ying Peng, Karl J. Clark, Jarryd M. Campbell, Magdalena R. Panetta, Yi Guo, Stephen Carl Ekker · 2014 · Development
  37. Coupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices
    Eugene V. Koonin, Feng Zhang · 2016 · BioEssays
  38. CRISPR/Cas9 and CAR-T cell, collaboration of two revolutionary technologies in cancer immunotherapy, an instruction for successful cancer treatment
    Hasan Mollanoori, Hojat Shahraki, Yazdan Rahmati, Shahram Teimourian · 2018 · Human Immunology
  39. INDEL detection, the ‘Achilles heel’ of precise genome editing: a survey of methods for accurate profiling of gene editing induced indels
    Eric Bennett, Bent Larsen Petersen, Ida Elisabeth Johansen, Yiyuan Niu, Zhang Yang, Christopher Aled Chamberlain, Özcan Met, Hans Heugh Wandall, Morten Frödin · 2020 · Nucleic Acids Research
  40. Advancing Therapeutic Strategies for Inherited Retinal Degeneration: Recommendations From the Monaciano Symposium
    Debra A. Thompson, Robin R. Ali, Eyal Banin, Kari E. H. Branham, John G. Flannery, David M. Gamm, William W. Hauswirth, John R. Heckenlively, Alessandro Iannaccone, Thiran Jayasundera et al. · 2015 · Investigative Ophthalmology & Visual Science
  41. CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer
    Shu Su, Zhengyun Zou, Fangjun Chen, Naiqing Ding, Juan Du, Jie Shao, Lin Li, Yao Shi Fu, Bian Hu, Yang Yang et al. · 2016 · OncoImmunology
  42. Targeted Deletion of an Entire Chromosome Using CRISPR/Cas9
    Fatwa Adikusuma, Nicole Williams, Frank Grützner, James Hughes, Paul Quinton Thomas · 2017 · Molecular Therapy
  43. Temporally coordinated signals progressively pattern the anteroposterior and dorsoventral body axes
    Francesca B. Tuazon, Mary C. Mullins · 2015 · Seminars in Cell and Developmental Biology
  44. CRISPR-Based Genome Editing Tools: Insights into Technological Breakthroughs and Future Challenges
    Muntazir Mushtaq, Aejaz Ahmad Dar, Milan Skalický, Anshika Tyagi, Nancy Bhagat, Umer Basu, Basharat Ahmad Bhat, Abbu Zaid, Sajad Ali, Tanvir Ul Hassan Dar et al. · 2021 · Genes
  45. Genome Editing in Human Stem Cells
    Susan M. Byrne, Prashant Mali, George McDonald Church · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
  46. Porcine Zygote Injection with Cas9/sgRNA Results in DMD-Modified Pig with Muscle Dystrophy
    Honghao Yu, Heng Zhao, Yubo Qing, Weirong Pan, Baoyu Jia, Hong‐Ye Zhao, Xingxu Huang, Hong‐Jiang Wei · 2016 · International Journal of Molecular Sciences
  47. Quantifying Protein-mRNA Interactions in Single Live Cells
    Bin Wu, Adina R. Buxbaum, Zachary Katz, Young J. Yoon, Robert H. Singer · 2015 · Cell
  48. Cell-Based Assay Design for High-Content Screening of Drug Candidates
    Gregory J. Nierode, Paul S. Kwon, Jonathan S. Dordick, Seok‐Joon Kwon · 2016 · Journal of Microbiology and Biotechnology
  49. Metabolic engineering of Bacillus subtilis fueled by systems biology: Recent advances and future directions
    Yanfeng Liu, Jianghua Li, Guocheng Du, Jian Chen, Long Liu · 2016 · Biotechnology Advances
  50. Correction of a splicing defect in a mouse model of congenital muscular dystrophy type 1A using a homology-directed-repair-independent mechanism
    Dwi U. Kemaladewi, Eleonora Maino, Elzbieta Hyatt, Huayun Hou, Maylynn Ding, Kara M Place, Xinyi Zhu, Prabhpreet S. Bassi, Zahra Baghestani, Amit G. Deshwar et al. · 2017 · Nature Medicine
  51. The emerging age of cell‐free synthetic biology
    Mark Thomas Smith, Kristen M. Wilding, Jeremy M. Hunt, Anthony M. Bennett, Bradley Charles Bundy · 2014 · FEBS Letters
  52. Programmable CRISPR‐Cas transcriptional activation in bacteria
    Hsing‐I Ho, Jennifer R. Fang, Jacky Cheung, Harris H. Wang · 2020 · Molecular Systems Biology
  53. CRISPR-Cas9 System for Plant Genome Editing: Current Approaches and Emerging Developments
    Jake Adolf V. Montecillo, Luan Luong Chu, Hanhong Bae · 2020 · Agronomy
  54. Nonsense suppression therapies in human genetic diseases
    Patrícia Martins-Dias, Luı́sa Romão · 2021 · Cellular and Molecular Life Sciences
  55. Molecular electronics sensors on a scalable semiconductor chip: A platform for single-molecule measurement of binding kinetics and enzyme activity
    Carl W. Fuller, Pius S. Padayatti, Hadi Abderrahim, Lisa Adamiak, Nolan Alagar, Nagaraj Ananthapadmanabhan, Jihye Baek, Sarat Chinni, Chulmin Choi, Kevin J. Delaney et al. · 2022 · Proceedings of the National Academy of Sciences
  56. Development of Novel Therapeutic Agents by Inhibition of Oncogenic MicroRNAs
    Dinh-Duc Nguyen, Suhwan Chang · 2017 · International Journal of Molecular Sciences
  57. Vitamin D Receptor Genotype, Vitamin D3 Supplementation, and Risk of Colorectal Adenomas
    Elizabeth L. Barry, Janet L. Peacock, Judy R. Rees, Roberd M. Bostick, Douglas J. Robertson, Robert S. Bresalier, John A. Baron · 2016 · JAMA Oncology
  58. Biomaterials as vectors for the delivery of CRISPR–Cas9
    Joon H. Eoh, Luo Gu · 2019 · Biomaterials Science
  59. Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies
    Maria Isabel G. Lopez Sanchez, Jonathan Guy Crowston, David Anthony Mackey, Ian Andrew Trounce · 2016 · Pharmacology & Therapeutics
  60. Systematic evaluation of CRISPR-Cas systems reveals design principles for genome editing in human cells
    Yuanming Wang, Kaiwen Ivy Liu, Norfala-Aliah Binte Sutrisnoh, Harini Srinivasan, Junyi Zhang, Jia Li, Fan Zhang, John Lalith Charles Richard, Heyun Xing, Raghuvaran Shanmugam et al. · 2018 · Genome biology
  61. State-of-the-art human gene therapy: part I. Gene delivery technologies.
    Dan Wang, Guangping Gao · 2014 · PubMed
  62. Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
    Raghuram Koganti, Tejabhiram Yadavalli, Deepak Shukla · 2019 · Microorganisms
  63. Advances in CRISPR/Cas9
    Youmin Zhu · 2022 · BioMed Research International
  64. Organoids as Models for Neoplastic Transformation
    James T. Neal, Calvin Jay Kuo · 2016 · Annual Review of Pathology Mechanisms of Disease
  65. The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
    Zhanhui Ou, Xiaohua Niu, Wenyin He, Yu‐Chang Chen, Bing Song, Yexing Xian, Di Fan, Daolin Tang, Xiaofang Sun · 2016 · Scientific Reports
  66. Genome editing in crop improvement: Present scenario and future prospects
    Gurbachan S. Miglani · 2017 · Journal of Crop Improvement
  67. State-of-the-art human gene therapy: part II. Gene therapy strategies and clinical applications.
    Dan Wang, Guangping Gao · 2014 · PubMed
  68. A CRISPR-based approach for proteomic analysis of a single genomic locus
    Zachary J. Waldrip, Stephanie D. Byrum, Aaron J. Storey, Jun Gao, Alicia K. Byrd, Samuel G. Mackintosh, Wayne P. Wahls, Sean D. Taverna, Kevin D. Raney, Alan J. Tackett · 2014 · Epigenetics
  69. Agricultural production: assessment of the potential use of Cas9-mediated gene drive systems for agricultural pest control
    Maxwell J. Scott, Fred L. Gould, Marcé D. Lorenzen, Nathaniel Grubbs, Owain Rhys Edwards, David A. O’Brochta · 2017 · Journal of Responsible Innovation
  70. CRISPR / C as9‐mediated gene knockout in the ascidian C iona intestinalis
    Haruka Sasaki, Keita Yoshida, Akiko Hozumi, Yasunori Sasakura · 2014 · Development Growth & Differentiation
  71. WormNet v3: a network-assisted hypothesis-generating server for Caenorhabditis elegans
    Ara Cho, Junha Shin, Sohyun Hwang, Chanyoung Kim, Hongseok Shim, Hyojin Kim, Hanhae Kim, Insuk Lee · 2014 · Nucleic Acids Research
  72. Building Potent Chimeric Antigen Receptor T Cells With CRISPR Genome Editing
    Jie Liu, Guangyu Zhou, Zhang Li, Qi Zhao · 2019 · Frontiers in Immunology
  73. Multiplex Engineering of Industrial Yeast Genomes Using CRISPRm
    Owen W. Ryan, Jamie H. D. Cate · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
  74. Huntingtin‐lowering strategies in Huntington's disease: Antisense oligonucleotides, small RNAs, and gene editing
    Neil Aronin M. D, Marian DiFiglia · 2014 · Movement Disorders
  75. Disruption of SUMO-Specific Protease 2 Induces Mitochondria Mediated Neurodegeneration
    Jiang Fu, H.-M. Ivy Yu, Shang-Yi Chiu, Anthony J. Mirando, Eri O. Maruyama, JrGang Cheng, Wei Hsu · 2014 · PLoS Genetics
  76. Imaging Specific Genomic DNA in Living Cells
    Baohui Chen, Juan Guan, Bo Huang · 2016 · Annual Review of Biophysics
  77. Genetic tools and techniques for Chlamydomonas reinhardtii
    Jan H. Mussgnug · 2015 · Applied Microbiology and Biotechnology
  78. CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection
    Hassen S. Wollebo, Anna Bellizzi, Rafal Kaminski, Wenhui Hu, Martyn K. White, Kamel Khalili · 2015 · PLoS ONE
  79. Elements and machinery of non‐coding RNAs: toward their taxonomy
    Tetsuro Hirose, Yuichiro Mishima, Yukihide Tomari · 2014 · EMBO Reports
  80. Highly efficient heritable targeted deletions of gene clusters and non-coding regulatory regions in Arabidopsis using CRISPR/Cas9
    Julius Dürr, Ranjith Kumar Papareddy, Keiji Nakajima, Jose Gutierrez‐Marcos · 2018 · Scientific Reports
  81. Precision genome engineering in lactic acid bacteria
    Jan Peter van Pijkeren, Robert A. Britton · 2014 · Microbial Cell Factories
  82. Bacteriophage-based synthetic biology for the study of infectious diseases
    Robert J. Citorik, Mark Mimee, Timothy K. Lu · 2014 · Current Opinion in Microbiology
  83. Adenovirus-Mediated Efficient Gene Transfer into Cultured Three-Dimensional Organoids
    Ning Wang, Hongyu Zhang, Bingqiang Zhang, Wei Liu, Zhonglin Zhang, Min Qiao, Hongmei Zhang, Fang Deng, Ningning Wu, Xian Chen et al. · 2014 · PLoS ONE
  84. Ethical Issues in Genome Editing using Crispr/Cas9 System
    Eduardo Rodrı́guez · 2016 · Journal of Clinical Research & Bioethics
  85. Mechanism of duplex DNA destabilization by RNA-guided Cas9 nuclease during target interrogation
    Vladimir M. Mekler, Минахин Леонид Станиславович, Konstantin Severinov · 2017 · Proceedings of the National Academy of Sciences
  86. Functional genomics to uncover drug mechanism of action
    Sebastian M. B. Nijman · 2015 · Nature Chemical Biology
  87. CRISPR/Cas9-mediated mutagenesis in the sea lamprey, Petromyzon marinus: a powerful tool for understanding ancestral gene functions in vertebrates
    Tyler A. Square, Marek Romášek, Dávid Jandzík, Maria V. Cattell, Michael W. Klymkowsky, Daniel Meulemans Medeiros · 2015 · Development
  88. CRISPR-Cas9 technology: applications in genome engineering, development of sequence-specific antimicrobials, and future prospects
    César de la Fuente‐Núñez, Timothy K. Lu · 2016 · Integrative Biology
  89. Strategies for In Vivo Genome Editing in Nondividing Cells
    Fatemeharefeh Nami, Mohsen Basiri, Leila Satarian, Cameron Curtiss, Hossein Baharvand, Catherine M. Verfaillie · 2018 · Trends in biotechnology
  90. CRISPR/Cas9-mediatedDax1knockout in the monkey recapitulates human AHC-HH
    Yu Kang, Bo Jian Zheng, Bin Shen, Yongchang Chen, Lei Wang, Jianying Wang, Yuyu Niu, Yiqiang Cui, Jiankui Zhou, Hong Wang et al. · 2015 · Human Molecular Genetics
  91. Silica-based nanoparticles for therapeutic protein delivery
    Meihua Yu, Zhengying Gu, Thomas Ottewell, Chengzhong Yu · 2017 · Journal of Materials Chemistry B
  92. Distinct patterns of Cas9 mismatch tolerancein vitroandin vivo
    Becky Xu Hua Fu, Robert P. St.Onge, Andrew Z. Fire, Justin Smith · 2016 · Nucleic Acids Research
  93. Improving the secretory capacity of Chinese hamster ovary cells by ectopic expression of effector genes: Lessons learned and future directions
    Henning Gram Hansen, Nuša Pristovšek, Helene Faustrup Kildegaard, Gyun Min Lee · 2016 · Biotechnology Advances
  94. New tools for redox biology: From imaging to manipulation
    Dmitry S. Bilan, Vsevolod Vadimovich Belousov · 2016 · Free Radical Biology and Medicine
  95. Regulation of transcriptionally active genes via the catalytically inactive Cas9 in C. elegans and D. rerio
    Lijiang Long, Hong Guo, Di Yao, Kai Xiong, Yongjun Li, Pengpeng Liu, Zuoyan Zhu, Dong Liu · 2015 · Cell Research
  96. CRISPR/Cas9-mediated targeted mutagenesis in upland cotton (Gossypium hirsutum L.)
    Madhusudhana R. Janga, LeAnne M. Campbell, Keerti S. Rathore · 2017 · Plant Molecular Biology
  97. Different Methods of Delivering CRISPR/Cas9 Into Cells
    Arun Pandian Chandrasekaran, Minjung Song, Kye-Seong Kim, Suresh Ramakrishna · 2018 · Progress in molecular biology and translational science
  98. Generation of e GFP and Cre knockin rats by CRISPR /Cas9
    Yuanwu Ma, Jing Ma, Xu Zhang, Wei Chen, Lei Yu, Yingdong Lu, Lin Bai, Bin Shen, Xingxu Huang, Lianfeng Zhang · 2014 · FEBS Journal
  99. Optimizing neuronal differentiation from induced pluripotent stem cells to model ASD
    Kim, Dae-Sung, Ross, P. Joel, Zaslavsky, Kirill, Ellis, James · 2014 · Frontiers in Cellular Neuroscience
  100. Functional interpretation of non‐coding sequence variation: Concepts and challenges
    Dirk S. Paul, Nicole Soranzo, Stephan Beck · 2013 · BioEssays